Skip to main content
. 2017 Aug 28;97(3):337–352. doi: 10.1093/biolre/iox094

Figure 7.

Figure 7.

Proposed treatment algorithm for ulipristal acetate use in uterine fibroid-related clinical profiles who desire fertility preservation. Different uterine fibroid-related clinical profiles who desire future fertility will administer ulipristal acetate or other oral agents for a 3-month cycle, up to four cycles, followed by close monitoring and retreatment as needed. ART, assisted reproductive techniques; SPRM, selective progesterone receptor modulator.